Medication Transport and Distribution: Introduction 101
SKS Medication Safety Series, Chapter 8 of 15 · Standard SİY07
Prof. Dr. Mehmet Nurullah Kurutkan, Düzce Üniversitesi İşletme Fakültesi Sağlık Yönetimi Bölümü
Chapter at a glance
Medicines must travel from the pharmacy to wards, theatres and emergency units without breakage, spillage, delay or mix-up. This chapter treats transport as part of the hospital drug distribution system and reviews evidence on centralised, decentralised and automated distribution. It corresponds to SKS SİY07 (Sağlık Bakanlığı, 2020).
Evidence base: 82 records of a 4948-record Web of Science corpus on hospital medication safety (Section 7). Reading time: about 25 minutes. Prior knowledge required: none.
Learning objectives
After working through this chapter, the reader should be able to:
- state the SKS SİY07 requirements for transfer of medicines;
- compare hospital drug distribution systems;
- summarise evidence on automated distribution and errors;
- recognise transport-specific risks.
Key concepts
- Drug distribution system: the organisation of supply from pharmacy to patient
- Ward pharmacy system: supply organised around ward stock replenished by pharmacy
- Decentralised distribution: storage and supply close to the patient, for example in cabinets
- Closed-loop system: linked prescribing, dispensing and administration with electronic tracking
- Transport safety: protection against breakage, spillage, loss and delay
Contents: How this chapter was produced · 1. Introduction · 2. History and development · 3. Definitions and conceptual schema · 4. Distinguishing it from neighbouring concepts · 5. Types and classifications · 6. Theoretical frameworks and models · 7. Themes and bibliometric profile · 8. The situation in Türkiye · 9. Debates and contradictions in the literature · 10. Measurement problems · 11. Research gaps and agenda · 12. Implications for practice today · Summary · Discussion questions · Further reading · Glossary · References · Source verification and AI use statement · Data and supplementary material
How this chapter was produced
Box 1. Method
Database: Web of Science Core Collection (SCI-EXPANDED, SSCI, ESCI); English; articles and reviews (including early access). Search date: 16 November 2026; all years (1981 to 2027).
Search: (#1 medication safety and error terms AND #2 hospital settings AND #3 fifteen SKS content blocks) NOT #4 animal and preclinical terms; the full string is on the series hub.
Screening: five export files (4955 records) were merged; 7 duplicates were removed by WoS accession number, DOI and normalised title plus year, leaving 4948 records. Records were assigned to this sub-topic when its term set (pneumatic tube, drug or medication distribution (system), transport of drugs or medications) appeared in the title or keywords or, for this thin sub-topic, the abstract; a record can belong to several sub-topics. Included here: 82 records (13 with the term in the title; 9 reviews).
Limitations: single database; English only; assignment by term matching, checked by reading titles of the most cited and most recent records; claims are checked against abstracts, not full texts.
4955 records
13 title matches; 9 reviews
other chapters or general records
1. Introduction
SKS asks for the equipment needed for safe transfer, measures against breakage and spillage during transport from stores, and training of transport staff in safe transfer and in responding to breakage of hazardous drugs (Sağlık Bakanlığı, 2020). In the literature, transport is rarely studied alone; it appears as part of the distribution system, whose design affects error rates at every downstream step.
2. History and development
The earliest record of the whole corpus (1981) concerns delivery time in a decentralised pharmacy system (Hibbard et al., 1981), and bar codes entered inpatient distribution in 1991 (Meyer et al., 1991). In 1997 failure mode and effects analysis was used to redesign a ward stock system (McNally et al., 1997). Comparative studies of national systems followed (Taxis et al., 1999), and the 2010s brought automated and semi-automated distribution (Ahtiainen et al., 2020; Cousein et al., 2014). A 2026 health technology assessment evaluates a closed-loop unit dose system (Croce et al., 2026).
- 1981 Delivery time in a decentralised pharmacy system (Hibbard et al., 1981).
- 1991 Bar codes in inpatient drug distribution (Meyer et al., 1991).
- 1997 FMEA redesign of a ward stock distribution system (McNally et al., 1997).
- 1999 Distribution systems in the UK and Germany compared (Taxis et al., 1999).
- 2014 Automated distribution reduces errors in a geriatric unit (Cousein et al., 2014).
- 2020 Systematic review of automated distribution systems (Ahtiainen et al., 2020).
- 2026 HTA of a closed-loop unit dose system (Croce et al., 2026).
3. Definitions and conceptual schema
| Source | Year | Discipline | Definition (paraphrased) | Emphasised dimension |
|---|---|---|---|---|
| Sağlık Bakanlığı, 2020 | 2020 | Accreditation standard | Transfer with suitable equipment, protection against breakage and spillage, and trained staff. | Physical safety |
| Taxis et al., 1999 | 1999 | Hospital pharmacy | Distribution system as the organisational route (ward pharmacy, unit dose, traditional) by which drugs reach patients. | Organisation |
| Ahtiainen et al., 2020 | 2020 | Health technology assessment | Automated and semi-automated systems evaluated for safety, time and cost. | Technology and economics |
| Croce et al., 2026 | 2026 | Health technology assessment | Closed-loop systems integrating electronic prescribing, automation and traceability. | Traceability |
medicines move from supply to patient through a designed route that preserves their integrity and identity
SKS focuses on physical integrity (Sağlık Bakanlığı, 2020); the research literature focuses on the organisational route and its error profile (Taxis et al., 1999).
4. Distinguishing it from neighbouring concepts
Transport and distribution overlap most with dispensing, administration and storage (Figure 4); in practice they are one supply chain.
| Neighbouring concept | How it differs |
|---|---|
| Storage (SİY04) | Concerns where medicines rest; distribution concerns how they move (Fontan et al., 2003). |
| Dispensing (SİY06) | Ends when the item leaves the pharmacy; transport begins then (Ahtiainen et al., 2020). |
| Controlled drugs (SİY11) | Require documented chain of custody during movement (Zheng et al., 2021). |
5. Types and classifications
Three distribution types are compared in the corpus: the ward pharmacy system, the unit dose system and the traditional ward stock system, each with distinct error stages (Taxis et al., 1999). Automated systems may be centralised, decentralised or hybrid (Ahtiainen et al., 2020).
6. Theoretical frameworks and models
Failure mode and effects analysis provides the main framework (McNally et al., 1997). Health technology assessment structures recent evaluations (Croce et al., 2026). Human factors appear in simulated transport environments, such as insulin errors during critical care air transport (Frasier et al., 2024).
7. Themes and bibliometric profile
Only 82 records match, most of them through the abstract. Unit dose distribution combined with computerised prescribing reduced prescription and administration errors compared with ward stock in a paediatric unit (Fontan et al., 2003), and automated distribution reduced wrong dose and wrong drug errors in a geriatric unit (Cousein et al., 2014). Figure 5 shows the profile.
Records per year 2026 (incomplete)
Most frequent journals
Most frequent countries
Most frequent author keywords: pharmacy, institutional, hospital (17), medication errors (16), drug distribution systems (15), errors, medication (12), automation (12), dispensing (11), administration (9), hospital pharmacy (9), clinical pharmacy (7), technology (7).
8. The situation in Türkiye
No transport or distribution record in the corpus has a Turkish address. SKS SİY07 requirements on equipment, spill prevention and staff training (Sağlık Bakanlığı, 2020) have not been evaluated in the indexed literature captured here.
9. Debates and contradictions in the literature
Which system is safest? Errors in ward pharmacy systems may be reduced by patient-specific storage, whereas traditional and unit dose systems benefit from using the original prescription for administration (Taxis et al., 1999): each system has its own weak points.
Centralise or decentralise? A systematic review suggests decentralised systems in small units save costs, but warns that new systems create new risks requiring training (Ahtiainen et al., 2020).
10. Measurement problems
Transport-specific outcomes (breakage, spillage, delays) are almost absent from the indexed literature. Studies measure errors at administration and attribute them to distribution design (Cousein et al., 2014; Taxis et al., 1999).
11. Research gaps and agenda
- How often do breakage and spillage of hazardous drugs occur during hospital transport? (no study found)
- Do pneumatic tube systems affect medication integrity or delays?
- What training content reduces transport incidents? (Sağlık Bakanlığı, 2020)
- How do closed-loop systems perform in Turkish hospitals? (Croce et al., 2026)
- Which distribution design best suits small hospitals? (Ahtiainen et al., 2020)
12. Implications for practice today
Treat transport as part of a designed distribution system: map it with FMEA (McNally et al., 1997), prefer patient-specific unit dose supply where feasible (Fontan et al., 2003), record transfers for traceability (Croce et al., 2026) and train porters in spill response as SKS requires (Sağlık Bakanlığı, 2020).
Summary
- Transport is part of the drug distribution system.
- SKS SİY07 requires equipment, spill prevention and staff training.
- Distribution design affects errors at administration.
- Automation reduces some errors but creates new risks.
- Transport-specific outcomes are almost unstudied.
Discussion questions
- Why is transport rarely studied on its own?
- Compare ward pharmacy, unit dose and traditional systems.
- What should a porter know about a broken cytotoxic vial?
- Map your hospital’s distribution route with an FMEA.
- What data would prove that a new distribution system is safer?
Further reading
- (Taxis et al., 1999): compares distribution systems across countries.
- (Ahtiainen et al., 2020): reviews automated distribution systems.
- (McNally et al., 1997): an early FMEA case.
- (Fontan et al., 2003): unit dose vs ward stock outcomes.
- (Croce et al., 2026): a recent HTA of closed-loop distribution.
Glossary
| Turkish | English | Short definition |
|---|---|---|
| İlaç dağıtım sistemi | Drug distribution system | Organisation of supply to patients |
| Merkezi olmayan dağıtım | Decentralised distribution | Supply close to the patient |
| Kapalı döngü sistem | Closed-loop system | Linked and tracked prescribing, dispensing and administration |
| Hata türü ve etkileri analizi | Failure mode and effects analysis | Prospective risk analysis method |
References
Ahtiainen, H. K., Kallio, M. M., Airaksinen, M., & Holmström, A. R. (2020). Safety, time and cost evaluation of automated and semi-automated drug distribution systems in hospitals: a systematic review. European Journal of Hospital Pharmacy, 27(5), 253-262. https://doi.org/10.1136/ejhpharm-2018-001791
Cousein, E., Mareville, J., Lerooy, A., Caillau, A., Labreuche, J., Dambre, D., Odou, P., Bonte, J. P., Puisieux, F., Decaudin, B., & Coupé, P. (2014). Effect of automated drug distribution systems on medication error rates in a short-stay geriatric unit. Journal of Evaluation in Clinical Practice, 20(5), 678-684. https://doi.org/10.1111/jep.12202
Croce, D., De Nardo, F., Convenga, F., Mueller, D., & Franzin, M. (2026). Health technology assessment of an automated unit-dose drug distribution system in a high-specialization national referral hospital of the Italian National Health Service. Global & Regional Health Technology Assessment, 13, 1-6. https://doi.org/10.33393/grhta.2026.3615
Fontan, J. E., Maneglier, V., Nguyen, V. X., Loirat, C., & Brion, F. (2003). Medication errors in hospitals: computerized unit dose drug dispensing system versus ward stock distribution system. Pharmacy World & Science, 25(3), 112-117. https://doi.org/10.1023/A:1024053514359
Frasier, L. L., Cheney, M., Burkhardt, J., Alderman, M., Nelson, E., Proctor, M., Brown, D., Davis, W. T., Smith, M. P., & Strilka, R. (2024). Identifying and Reducing Insulin Errors in the Simulated Military Critical Care Air Transport Environment: A Human Factors Approach. Military Medicine, 190(1-2), 342-350. https://doi.org/10.1093/milmed/usae286
Hibbard, F. J., Bosso, J. A., Sward, L. W., & Baum, S. (1981). Delivery time in a decentralized pharmacy system without satellites. American Journal of Hospital Pharmacy, 38(5), 690-692. https://doi.org/10.1093/ajhp/38.5.690
McNally, K. M., Page, M. A., & Sunderland, V. B. (1997). Failure-mode and effects analysis in improving a drug distribution system. American Journal of Health-System Pharmacy, 54(2), 171-177. https://doi.org/10.1093/ajhp/54.2.171
Meyer, G. E., Brandell, R., Smith, J. E., Milewski, F. J., Brucker, P., & Coniglio, M. (1991). Use of bar codes in inpatient drug distribution. American Journal of Hospital Pharmacy, 48(5), 953-966. https://doi.org/10.1093/ajhp/48.5.953
Sağlık Bakanlığı. (2020). Sağlıkta kalite standartları: Hastane (Sürüm 6.1). Sağlık Hizmetleri Genel Müdürlüğü, Sağlıkta Kalite, Akreditasyon ve Çalışan Hakları Dairesi Başkanlığı. https://dosyamerkez.saglik.gov.tr/Eklenti/41258/0/skshastane-seti-s-61–09082021pdf.pdf
Taxis, K., Dean, B., & Barber, N. (1999). Hospital drug distribution systems in the UK and Germany – a study of medication errors. Pharmacy World & Science, 21(1), 25-31. https://doi.org/10.1023/A:1008616622472
Zheng, W. Y., Lichtner, V., Van Dort, B. A., & Baysari, M. T. (2021). The impact of introducing automated dispensing cabinets, barcode medication administration, and closed-loop electronic medication management systems on work processes and safety of controlled medications in hospitals: A systematic review. Research in Social & Administrative Pharmacy, 17(5), 832-841. https://doi.org/10.1016/j.sapharm.2020.08.001
Source verification and AI use statement
Source verification. All 11 references were generated programmatically from the Web of Science records of the corpus, so authors, year, title, journal and DOI match the records exactly; every in-text citation was cross-checked by code against the reference list. Claims were checked against the record abstracts; full texts were not read. The SKS Hospital Set (Version 6.1) is the only source outside the corpus; it was accessed and read for this chapter.
AI use statement. Claude (Anthropic) was used to merge and de-duplicate the Web of Science exports, assign records to sub-topics, compute the bibliometric indicators and figures, and draft the text under the author’s instructions. The author is responsible for the final content.
Data and supplementary material
Supplementary file S1 (Excel) lists the 82 records of this chapter (authors, year, title, journal, DOI, title match flag), together with the full screening log of the 4948-record corpus and the citation verification report. The list is not reproduced here; it is available from the author on request.
← Chapter 7: Medication Preparation and DispensingChapter 9: Safe Medication Administration →